Sutro Biopharma Inc (NASDAQ: STRO) is -22.61% lower on its value in year-to-date trading and has touched a low of $2.01 and a high of $6.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The STRO stock was last observed hovering at around $3.40 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $3.32, the stock is -21.22% and -18.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.65 million and changing -2.35% at the moment leaves the stock -18.92% off its SMA200. STRO registered -0.30% loss for a year compared to 6-month gain of -20.57%. The firm has a 50-day simple moving average (SMA 50) of $4.0442 and a 200-day simple moving average (SMA200) of $4.0945.
The stock witnessed a -33.06% loss in the last 1 month and extending the period to 3 months gives it a 13.12%, and is -15.95% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.39% over the week and 8.54% over the month.
Sutro Biopharma Inc (STRO) has around 302 employees, a market worth around $272.11M and $169.36M in sales. Profit margin for the company is -73.48%. Distance from 52-week low is 65.59% and -45.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.07%).
Sutro Biopharma Inc quarterly earnings per share for the current quarter are estimated at -0.73 with sales reaching $15.29M over the same period.The EPS is expected to shrink by -66.03% this year, but quarterly earnings will post -57.00% year-over-year.
170.0 institutions hold shares in Sutro Biopharma Inc (STRO), with institutional investors hold 78.89% of the company’s shares. The shares outstanding are 81.96M, and float is at 75.85M with Short Float at 3.95%. Institutions hold 78.13% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 6.91 million shares valued at $20.25 million. The investor’s holdings represent 11.2447 of the STRO Shares outstanding. As of 2024-06-30, the second largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with 7.71 million shares valued at $22.59 million to account for 9.4906 of the shares outstanding. The other top investors are MILLENNIUM MANAGEMENT LLC which holds 4.36 million shares representing 7.0974 and valued at over $12.78 million, while VANGUARD GROUP INC holds 5.785 of the shares totaling 3.56 million with a market value of $10.42 million.
Sutro Biopharma Inc (STRO) Insider Activity
The most recent transaction is an insider sale by Vasquez Nicki, the company’s CHIEF PORT. STRAT & ALNCE OFCR. SEC filings show that Vasquez Nicki sold 12,185 shares of the company’s common stock on Jan 29 ’24 at a price of $5.00 per share for a total of $60925.0. Following the sale, the insider now owns 12803.0 shares.
